Maxim De Schepper
Impact in
-
- Breast Cancer Treatment Studies
- Cancer, Lipids, and Metabolism
-
- Cancer Cells and Metastasis
- Cancer Risks and Factors
- Inflammatory Biomarkers in Disease Prognosis
- HER2/EGFR in Cancer Research
Papers in
- Oncology 8
- Cancer Cells and Metastasis 2
- Cancer Risks and Factors 2
- Cancer Immunotherapy and Biomarkers 2
-
- Breast Cancer Treatment Studies 2
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Christine Desmedt (11 shared papers)François Richard (10 shared papers)Giuseppe Floris (10 shared papers)Marion Maetens (9 shared papers)Denis Larsimont (2 shared papers)Delphine Vincent (1 shared paper)Christos Sotiriou (2 shared papers)Ghizlane Rouas (2 shared papers)
- Journals
- The Breast (3 papers)Modern Pathology (3 papers)ESMO Open (2 papers)The Journal of Pathology (1 paper)npj Breast Cancer (1 paper)
- Partner nations
- BelgiumUnited StatesItaly
In The Last Decade
Maxim De Schepper
7 papers receiving 28 citations
Peers
Comparison fields: 5 of 13
- Cancer Research 18
- Oncology 20
- Pathology and Forensic Medicine 6
- Pulmonary and Respiratory Medicine 9
- Epidemiology 9
Countries citing papers authored by Maxim De Schepper
This map shows the geographic impact of Maxim De Schepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim De Schepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim De Schepper more than expected).
Fields of papers citing papers by Maxim De Schepper
This network shows the impact of papers produced by Maxim De Schepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim De Schepper. The network helps show where Maxim De Schepper may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxim De Schepper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 8 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 0 | |
| 11 | 2024 | 0 | |
| 12 | 2024 | 0 |
About Maxim De Schepper
Maxim De Schepper is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 29 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Cells and Metastasis (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Breast Lesions and Carcinomas (2 papers), Cancer Risks and Factors (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Cancer Research (18 citations), Oncology (20 citations), Pathology and Forensic Medicine (6 citations), Pulmonary and Respiratory Medicine (9 citations) and Epidemiology (9 citations). Maxim De Schepper has collaborated with scholars based in Belgium, United States and Italy. Frequent co-authors include Christine Desmedt, François Richard, Giuseppe Floris, Marion Maetens, Denis Larsimont, Delphine Vincent, Christos Sotiriou, Ghizlane Rouas, Tatjana Geukens and Edoardo Isnaldi. Their work appears in journals such as The Breast, Modern Pathology, ESMO Open, The Journal of Pathology and npj Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.